Comparative opsonic activity of intravenous gamma globulin preparations for common bacterial pathogens.
暂无分享,去创建一个
[1] R. Buckley. Long term use of intravenous immune globulin in patients with primary immunodeficiency diseases: Inadequacy of current dosage practices and approaches to the problem , 1982, Journal of Clinical Immunology.
[2] M. Collins,et al. Protective activity of an intravenous immune globulin (human) enriched in antibody against lipopolysaccharide antigens of Pseudomonas aeruginosa. , 1984, The American journal of medicine.
[3] H. Hill,et al. Strain Differences in Virulence of Group B Streptococci , 1982, Pediatric Research.
[4] H. Hill,et al. Protective efficacy of a modified immune serum globulin in experimental group B streptococcal infection. , 1981, The Journal of pediatrics.
[5] J. Lundblad,et al. A New Preparation of Modified Immune Serum Globulin (Human) Suitable for Intravenous Administration , 1981, Vox sanguinis.
[6] H. Hill,et al. Strain specificity of opsonins for group B streptococci types II and III , 1979, Infection and immunity.
[7] J. White,et al. In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood. , 1967, The Journal of clinical investigation.